Fertility Testing Devices Market Size - By Product Type (Ovulation Prediction Kits, Fertility Monitors, Male Fertility Test Kits), By Purchase Mode (OTC, Prescription), Gender, End User (Home Care Setting, Fertility Clinics & Hospitals) & Forecast, 2021-2027

Fertility Testing Devices Market Size

Fertility Testing Devices Market Size exceeded USD 580 million in 2020 and will witness over 6.4% CAGR from 2021 to 2027. Increasing prevalence of infertility issues in adults due to sedentary and unhealthy lifestyle, growing awareness about family planning, and delayed first time pregnancy in women are some of the prominent factors that are expected to facilitate the market growth during the forecast timeframe. Moreover, popularity of self-assessing fertility test kits will further propel the market expansion. The impact of COVID-19 on the fertility testing devices business is observed to be moderate as in few parts of the world pregnancy amid pandemic rose and in some regions it declined.
 

Fertility tests are an essential part of fertility evaluation and treatment. Through fertility testing, one can possibly discover what's preventing them from achieving pregnancy. The fertility testing devices work by measuring hormonal levels of ones’ body and providing hormone profiles. These hormone profiles of the individuals are based on condition such as their cycle duration, any fertility disorder or on the basis of any drug or treatment taken by them. Few of fertility testing devices, such as fertility monitors give results by detecting high ovulating days by monitoring body temperature and other physiological factors. Fertility testing devices primarily include, ovulation kits, semen analysis kits and fertility monitors. The purpose of these kits is to detect information regarding sperm count in men, and peak ovulating days in women, that may help them plan or avoid a pregnancy accordingly.
 

Technological advancements and availability of home-based fertility kits will boost the fertility testing devices market

Earlier, the testing procedures included manual lab-based testing and computer assisted semen analysis system that were time taking as well as expensive. To combat such issues, companies manufacturing fertility testing devices are focusing on development of advanced testing kits that are smartphone-based and provide rapid results. For instance, in March 2017, Scientists from Massachusetts General Hospital (MGH) developed smartphone-based semen analyzer for fertility testing in men. This testing kit is easy to use, inexpensive and fully automated. Also, in 2018, Brigham and Women Hospital in Massachusetts developed cost effective smartphone application that can predict a woman’s ovulation cycle. The testing kit is made using microfluidic technology, and artificial intelligence (AI). This device automatically detects fern-like patterns from saliva sample which is marker of ovulation.
 

Fertility Testing Devices Market Analysis

Male fertility kits segment captured more than 11% of the market share in 2020 led by the increasing infertility issues in men worldwide. For instance, according to the Lancet report published in 2020, nearly 8-12% of couples globally are facing problem of infertility, with the males being primary cause in around 50% of couples. The causes of male infertility are many. It may be due to any physical abnormality, it may be acquired, or it could be an idiopathic factor. For instance, it has been reported that around 15% of men suffer with infertility, though they have normal semen and normal sperm count. Thus, fertility testing device manufacturers are coming up with specialized male fertility kits, such as anti-sperm antibody SFT kit, semen pH kit, and different morphology kits to detect all the possibilities that contributes to infertility in men.
 

Over the counter (OTC) segment in the fertility testing devices market was valued at over USD 460 million in 2020 owing to the increasing availability of home-based kits, increasing prescription cost, and effective regulation of OTC products by government bodies to ensure effectiveness of product as well as safety of consumer.
 

Female segment is poised to showcase 6.3% growth rate through 2027.  This is mainly attributed to recurrent usage of ovulation kits and increasing cases of infertility in women. According to global burden of disease study conducted in 2017, the prevalence rate of female infertility increased from 1,366.85 per 100,000 in 1990 to 1,571.35 per 100,000 in 2017 showing an increase of 0.37% per year.
 

The home care setting segment captured USD 315 million in 2020. The segment growth is credited to the availability of testing devices, that can be used without the help of professionals. For instance, the Mira fertility plus system is almost like having a mini fertility lab at home which predicts ovulation with accurate LH and E3G concentrations. Such fertility testing devices does not require any professional help for its use. Another fertility device by Ava Science Inc, is bracelet that helps in detecting 5.3 fertile days in each cycle by monitoring body temperature, resting pulse rate, heart rate, and sleep. Therefore, leverage of tracking one’s cycles at home without paying regular visits to fertility clinics is slated to propel the segment expansion during the forecast period.
 

North America fertility testing devices market held over 36% of revenue share in 2020 on account of the lifestyle changes leading to infertility disorders. For instance, according to CDC report, the general fertility rate in U.S. in 2020 was 56 births per 1000 woman. It was nearly a half of what it was in 1960’s. Besides infertility issues, increasing adolescent pregnancy in the region is also driving the industry expansion.
 

Fertility Testing Devices Market Share

Some of the prominent companies operating in the market include:

• Fertility Focus Limited
• Geratherm Medical AG
• UEBE Medical GmbH
• Church & Dwight Co Inc
• Ava AG
• Fairhaven Health
• Lady Technologies
• SPD Swiss Precision Diagnostics GmbH
• Samplytics Technologies Private Limited
• The Boots Company PLC (Walgreens Boots Alliance)
• SNOWDEN
• AdvaCare Pharma USA
• HiLin Life Products Inc.

These market participants are implementing various growth strategies to sustain the industry competition.
 

The fertility testing devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Click here to Buy Section of this Report

Market, By Product Type, 2016-2027 (USD Million)

• Ovulation Prediction Kits
• Fertility Monitors
• Male Fertility Test Kits

Market, By Purchase Mode, 2016-2027 (USD Million)

• OTC
• Prescription

Market, By Gender, 2016-2027 (USD Million)

• Female
• Male

Market, By End User, 2016-2027 (USD Million)

• Home Care Settings
• Fertility Clinics & Hospitals
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa